英文别名 |
GINSENOSIDEF1;(20S)-20-(β-D-Glucopyranosyloxy)dammar-24-ene-3β,6α,12β-triol;3β,6α,12β-Trihydroxy-5α-dammar-24-en-20-yl β-D-glucopyranoside;(3b,6a,12b)-3,6,12-Trihydroxydammar-24-ene-20-yl beta-D-glucopyranoside;GINSENOSIDE F1(P);20(S)-Ginsenoside F1(3b,6a,12b)-3,6,12-Trihydroxydammar-24-ene-20-yl beta-D-glucopyranoside;20(S)-Ginsenoside F1;Ginsenoside-F1;Ginsenoside F1;(2R,3S,4R,5S,6S)-2-(Hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-t;MFCD06410947;MFCD06410947;(20S)-ginsenoside F1;(20S)-ginsenoside F1;20(S)-ginsenoside F1;20(S)-ginsenoside F1;Q-100611;Q-100611;DTXSID00968777;DTXSID00968777;CHEBI:77150;CHEBI:77150;Ginsenoside F1, >=98% (HPLC);Ginsenoside F1, >=98% (HPLC);(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol;(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol;(beta,6alpha,12beta)-3,6,12-trihydroxydammar-24-en-20-yl beta-D-glucopyranoside;(beta,6alpha,12beta)-3,6,12-trihydroxydammar-24-en-20-yl beta-D-glucopyranoside;Q27146705;Q27146705;AKOS037514665;AKOS037514665;s9299;s9299;C20780;C20780;AS-76768;AS-76768;CCG-270314;CCG-270314;CS-3842;CS-3842;CHEMBL584011;CHEMBL584011;HY-N0598;HY-N0598;53963-43-2;53963-43-2;A)-3,6,12-trihydroxydammar-24-en-20-yl ;(3;SY068854;SCHEMBL21297623;A,6;A-D-glucopyranoside;A,12;panaxoside A progenin |